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ABSTRACT: Intestinalmucins trigger immune responses upon recognition bydendritic cells viaprotein–carbohydrate
interactions. We used a combination of structural, biochemical, biophysical, and cell-based approaches to decipher
the specificity of the interaction between mucin glycans and mammalian lectins expressed in the gut, including
galectin (Gal)-3 and C-type lectin receptors. Gal-3 differentially recognized intestinal mucins with different
O-glycosylationprofiles, asdeterminedbymassspectrometry (MS).Modificationofmucinglycosylation,via chemical
treatment leading to a loss of terminal glycans, promoted the interaction of Gal-3 to poly-N-acetyllactosamine.
Specific interactions were observed betweenmucins andmouse dendritic cell-associated lectin (mDectin)-2 or specific
intercellular adhesion molecule–grabbing nonintegrin-related-1 (SIGN-R1), but not mDectin-1, using a cell-reporter
assay, as also confirmed by atomic force spectroscopy. We characterized the N-glycosylation profile of mouse colonic
mucin (Muc)-2 by MS and showed that the interaction with mDectin-2 was mediated by high-mannose N-glycans.
Furthermore, we observed Gal-3 binding to the 3 C-type lectins by force spectroscopy. We showed that mDectin-1,
mDectin-2, and SIGN-R1 are decorated byN-glycan structures that can be recognized by the carbohydrate recognition
domain of Gal-3. These findings provide a structural basis for the role of mucins in mediating immune responses and
new insights into the structure and function of major mammalian lectins.—Leclaire, C., Lecointe, K., Gunning, P. A.,
Tribolo, S., Kavanaugh,D.W.,Wittmann, A., Latousakis, D.,MacKenzie, D. A., Kawasaki, N., Juge, N.Molecular basis
for intestinal mucin recognition by galectin-3 and C-type lectins. FASEB J. 32, 3301–3320 (2018). www.fasebj.org
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Themucosal immune system comprises the largest part of
the entire immunesystem. In thegastrointestinal (GI) tract,
goblet cells (GCs) have an established role in innate
immunity by secreting mucins, a major component of the
mucus layer (1, 2), which provides a first line of defense
against physical and chemical injury and protects against
invasion by pathogens (3, 4). All mucins are characterized
by mucin domains rich in Ser, Thr, and Pro amino acid
residues, which are the site of heavy O-glycosylation.
MUC2, -5AC, -6, and -5B are themain gel-formingmucins
secreted byGCs in the intestine, stomach surface, stomach
glands, and salivaryglands, respectively (4). In addition to
the central mucin domains, gel-forming mucins have
N- and C-terminal domains that are involved in mucin
dimerization, oligomerization, polymerization, and the
formationof theprotectivemucus gels (5). The intestinal
mucus is built around the large highly glycosylated gel-
forming MUC2 (Muc2 in mouse) (6, 7). In the small in-
testine (SI), a loose and penetrable mucus layer allows
smooth transport of nutrients while reducing mucosal
exposure to damaging agents. In the large intestine,
mucus shows a bilayer organization with the outer
mucus layer providing a natural habitat for the com-
mensal bacteria, whereas the stratified inner mucus
layer restricts bacterial access to the epithelium (8, 9).
The delivery of luminal substances across the intestinal
mucus and epithelium to the immune system is a critical
event in immune surveillance, resulting in tolerance to
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dietary antigens and immunity to pathogens. Recently,
GC-associated passages were identified as a pathway de-
livering luminal antigens to underlying lamina propria
dendritic cells (DCs) in the steady state (10). The mecha-
nism of this uptake is not fully understood (11), but it is
believed to be coupled tomucin secretion (12) and involves
sentinel GCs localized to the colonic crypt entrance (13).
The glycan structures present in mucins are di-
verse and complex and consist of 4 core mucin-type
O-glycans containing N-acetylgalactosamine (Gal-
NAc), galactose and N-acetylglucosamine (GlcNAc).
Mucin O-glycosylation starts in the Golgi apparatus
with the attachment of GalNAc residues to the hy-
droxyl group of Ser or Thr of the protein backbone to
form the Tn antigen (GalNAca1-Ser/Thr). This glycan
is then elongated into core-1 [Galb1-3GalNAca1-Ser/
Thr, also known as Thomsen-Friedenreich- (TF-), or
T-antigen], core-2 (Galb1-3(GlcNAcb1-6)GalNAca1-
Ser/Thr), core-3 (GlcNAcb1-3GalNAca1-Ser/Thr), or
core-4 [GlcNAcb1-3(GlcNAcb1-6)GalNAca1-Ser/Thr]
structures (14). Core-1– and -3–derived mucin-type
O-linked oligosaccharides (O-glycans) are major com-
ponents of the colonic mucus layer (15–17). These core
structures may be further elongated by the addition of
other carbohydrates [e.g., N-acetyllactosamine (Lac-
NAc)] or terminally modified by fucose, sialic acid, or
sulfate groups. O-glycans can exhibit a remarkable het-
erogeneity and diversity, as mucins can also carry ABO
or Lewis-type histo-blood group epitopes (18). The ratio
of sialic acid to fucose increases along the GI tract, from
the ileum to the distal colon in humans (17), whereas an
inverse gradient is found in mice (19). Charged glycans
such as the Sd/CADepitope [GalNAcb1–4(NeuAca2–3)
Galb12] are more predominant in the human distal
colon, whereas fucosylated glycans (ABO histo-blood
group antigens) aremore abundant in the proximal parts
of the intestine (16). Abrogation of mucin O-glycans has
highlighted the role of specific glycan chains ofmucins in
maintaining mucosal barrier function (20). For example,
mice lacking core-3 b1,3-N-acetylglucosaminyltransfer-
ase (C3GnT), an enzyme involved in the biosynthesis of
core-3–derived O-glycans showed increased permeabil-
ity and susceptibility to experimental colitis and cancer
(21–23). In contrast to the extensive O-glycosylation of
the central regions of mucins, component N-glycans are
in relatively low abundance and largely confined to the
end regions of the molecule but are important for mucin
dimer formation (24, 25). Because of their high degree of
glycosylation (up to 80% of the mucin mass is carbohy-
drate), mucins constitute potential binding partners for
mammalian lectins.
Carbohydrate structures in mucins can trigger DC-
mediated immune responses through interactions with
membersof theC-type lectin receptor (CLR) family (26, 27).
Of particular interest are DC-associated C-type lectin
(dectin)-1 and -2, which possess single carbohydrate
recognition domains (CRDs) in their extracellular re-
gion (28, 29). They are expressed mainly in DCs and
macrophages. These CLRs have traditionally been as-
sociated with the recognition of fungi and bacteria (30),
but recent discoveries have revealed emerging roles in
homeostasis, autoimmunity, allergy, and recognition of
dead and cancerous cells (31). It was recently shown that
glycans associated with Muc2 generate gut homeostasis
and tolerance by assembling a signal-transducing Dec-
tin-1-FcgRIIB complex on DCs with the help of soluble
galectin (Gal)-3 (32). This association resulted in the ac-
tivation of b-catenin transcription factor that interfered
with DC expression of inflammatory, but not anti-
inflammatory, cytokines by inhibiting gene transcrip-
tion through NF-kB (32). Another well-characterized
C-type lectin is dendritic cell-specific intercellular adhe-
sion molecule-3-grabbing non-integrin (DC-SIGN),
which binds terminal fucose (33). Recently, the lectin
domain of DC-SIGN was found to bind to the glyco-
protein MUC1 from human milk, preventing pathogen
interaction through the presence of Lewis X-type oligo-
saccharides (34).
Gal-3 is expressed in several cell typesand is involved in
a broad range of physiologic and pathologic processes,
such as cell adhesion, cell activation, chemoattraction, cell
cycle, apoptosis, and cell growth and differentiation (35).
Earlier studies reported Gal-3 interaction with different
mucins, including the ocular cell surface MUC, MUC1
and -16, in a galactose-dependentmanner (36) or to cancer
mucins from human colon cancer cell lines (37). Structural
studies have shown that Gal-3 binds to the TF antigen,
Galb1-3GalNAca1-Ser/Thr, themucin core-1 structure of
O-glycans appearing on the cancer-associated trans-
membrane mucin protein MUC1 (38, 39).
These observations demonstrate novel ways in which
mucins contribute to the regulation of the host immune
system. In this study, we showed, using a combination of
in vitro, cell-based, and force spectroscopy assays that
mucins could directly interact with Gal-3, mDectin-2, and
SIGN-R1 (the murine homolog of DC-SIGN), providing a
structural basis for how mucus delivers tolerogenic sig-
nals. Furthermore, we showed that Gal-3 recognized
mDectin-1, mDectin-2, and SIGN-R1 via carbohydrate-
lectin interactions with glycans decorating C-type lectins,
uncovering a novel mechanism by which mammalian
lectins may modulate inflammatory responses.
MATERIALS AND METHODS
Materials
All chemical reagents are fromMilliporeSigma (Go¨ttingen, Ger-
many), unless stated otherwise. Recombinant proteins including
murine (m)Dectin-1 (mDectin-1) and -2, human (h)Dectin-1 and -2
and DC-SIGNwere purchased from R&D Systems (Abingdon,
United Kingdom), murine SIGN-R1 was from Sino Biologic
(Beijing, China). TheNSOcell linewas used formDectin-1 and -1
andhDectin-1 and -2 recombinantproduction,CHOcell linewas
used for recombinant production DC-SIGN and human embry-
onic kidney cells for recombinant SIGN-R1. Antibodies used in
the study include mouse monoclonal anti-Gal-3 (R&D Systems)
and goat anti-mouse IgG horseradish peroxidase conjugate
(MilliporeSigma). The following fluorescein labeledplant lectins,
wheat germ agglutinin (WGA), Ricinus communis agglutinin
(RCA), andUlexeuropaeusagglutinin (UEA) ,wereobtained from
Vector Laboratories (Peterborough, United Kingdom), b-1,6-
galactobiose (galactobiose) from Dextra Labs (Reading, United
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Kingdom), and scleroglucan from Elicity (Crolles, France).
C3GnT2/2 mice were from Dr. Lijun Xia (University of Okla-
homa Health Sciences Center, Oklahoma City, OK, USA).
Cell culture
LS174T cells were cultured in DMEM supplemented with 10%
fetal bovine serum, 2 mM L-glutamine, and 1% nonessential
amino acids. BWZ.36 reporter cells were cultured in RPMI 1640
media supplemented with 10% fetal bovine serum, 100 U/ml
penicillin and streptomycin, 2mML-glutamine, and 50mM2-ME
(R10 medium).
Gal-3 expression and purification
The cDNA coding for human Gal-3 was synthesized by Gen-
Script (Piscataway, NJ, USA) and supplied in vector pUC57. 59
Terminal NdeI and 39 terminal BamHI restriction sites were in-
cluded for subsequent cloning. The Gal-3 encoding cDNA was
cloned as an NdeI–BamHI fragment into expression vector pET-
15b (Novagen, Watford, United Kingdom) which has a
thrombin-cleavable N-terminal His6tag and transformed into
Escherichia coli DH5a to produce plasmid DNA for sequencing.
The pET-15b vector with the correct insert sequence was then
transformed into E. coli expression strain TUNER(DE3) (Nova-
gen). Cultureswere grown in lysogenybroth containing 100mg/
ml carbenicillin and 1% (w/v) glucose to OD;1.0 at which time
protein expression was induced with 1 mM isopropyl b-D-1-
thiogalactopyranoside for 4 h at 37°C. Cells were harvested by
centrifugation at 10,500 g for 10 min at 4°C, resuspended in PBS,
and lysed by sonication on ice. Cellular debris was removed by
centrifugationat 10,000g for10min.The cell lysate containing the
recombinant Gal-3 protein was then purified using an a-lactose
agaroseaffinity column (MilliporeSigma).Gal-3waselutedusing
150 mM lactose (MilliporeSigma) in PBS, and all positive frac-
tions forGal-3were pooled and buffer exchanged inHis-binding
solution [20mMTris, 500 mMNaCl, 10 mM imidazole (pH 7.9)]
using a P10 disposable desalting columns (GE Healthcare, Little
Chalfont, United Kingdom). Gal-3-rich fractions were then fur-
ther purified using immobilized metal ion affinity chromatog-
raphy and eluted with 250 mM imidazole. Eluted proteins were
buffer exchanged with PBS using Vivaspin 6 (3 kDa; Milli-
poreSigma) spin filter exchange columns. Protein purity was
assessed by SDS-PAGE. Purified protein was aliquoted and
stored at220°C.
ELISA-type assay of binding of Gal-3 to mucins
Native andmodifiedmucins were adsorbed onto a 96-well plate
(Maxisorp; Thermo Fisher Scientific, Waltham, MA, USA) at
10 mg/ml in PBS overnight at 4°C.Wells were washed with PBS
containing 0.05% Tween-20 and blocked with 1% bovine serum
albumin in PBS for 2 h. Wells were sequentially washed and
incubated with 5 mg/ml of Gal-3 (diluted in blocking buffer) for
2 h at 37°C. For the inhibition assays, Gal-3 was prepared in
blocking buffer containing 100mM lactose.After furtherwashes,
amousemonoclonal anti-Gal-3was added at a 1:5000 dilution in
blockingbuffer and incubated at 37°C for 1h.Wellswerewashed
as above and goat anti-mouse IgG horseradish peroxidase con-
jugate was added to eachwell at a 1:5000 dilution and incubated
for 45 min at 37°C. After final washes, the presence of Gal-3 was
detected by addition of TMBHigh Sensitivity Substrate Solution
(BioLegend, SanDiego, CA,USA). The colorimetric reactionwas
stopped by adding an equal volume of 2 N sulfuric acid (H2SO4)
and read at 450 nm with a Benchmark Plus Microtiter Plate
Reader (Bio-Rad, Hercules, CA, USA).
Atomic force microscopy and force spectroscopy
The atomic force microscope used in this study was an MFP-3D
BIO (Asylum Research, Santa Barbara, CA, USA). Force spec-
troscopy experiments were conducted by using DC mode in
Dulbecco’s PBS (MilliporeSigma).
Tip and slide functionalization
Silicon nitride atomic force microscopy (AFM) probe tips (PNP-
TR;NanoWorld,Neuchaˆtel, Switzerland)were functionalizedby
using a 4-step procedure (at 21°C). In the first step, the tips were
incubated in a 2%solutionof 3-mercaptopropyltrimethoxy silane
(MilliporeSigma) in dried toluene (4 A˚ molecular sieve) for 2 h,
followed by washing with toluene and then chloroform. In the
second step, the silanized tips were incubated for 1 h in a 0.1%
solution of a linear heterobifunctional polyethylene glycol (PEG)
linker in chloroform, which contains a maleimide (MAL)and a
succinimidyl N-hydroxysuccinimide ester group [2 kDa MAL-
PEG- succinimidyl carboxyl methyl ester (SCM); Creative PEG-
Works, Durham,NC, USA], on each end of the PEG chain. MAL
reacts with the mercapto groups (SH) on the AFM tip and SCM
reacts with primary amines in the receptor proteins. Unbound
MAL-PEG-SCM was washed off with chloroform, and the tips
were dried with argon. The third step involved covalent attach-
ment of lectins (Gal-3, mDectin-1, mDectin-2, SIGN-R1, hDectin-
1, hDectin2, andDC-SIGN) by incubation of the tips in 1 mg/ml
lectin solutions in PBS (pH 7.4) for 1 h at 21°C, followed by a PBS
washing step. In the fourth step, the lectin-functionalized canti-
leverswere incubated in a 10mg/ml solution of glycine in PBS to
amine cap any unreacted succinimide groups, followed by
washing in PBS. Lectin-functionalized tips were stored under
PBS at 4°C overnight before use.
Attachment of receptors onto glass slides
The functionalization of glass slides was performed by initial
silanization with 3-mercaptopropyltrimethoxy silane, as for the
AFM tips, followed by attachment of a different heterobifunc-
tional linker molecule, N-g-maleimidobutyryl-oxysuccinimide
ester (Thermo Fisher Scientific). A drop (100 ml) of the receptor
molecules (mDectin-1, Gal-3, or mucins) at 1 mg/ml in PBS was
placed onto the derivatized slides for 1 h at room temperature to
link the proteins via their N termini, followed bywashing in PBS.
The surfaceswere incubated in a 10mg/ml solution of glycine to
amine cap any unreacted succinimide groups on the glass, and
then washed in PBS to remove any unbound glycine, before be-
ing inserted into the liquid cell of the AFM.
Enzymatic treatment on slide
The functionalized slideswere transferred into a sealedglass box
with a damp section of tissue on the base to prevent evapo-
ration during the enzymatic treatment. PeptideN-glycosidase
(PNGase) F (200 ml; MilliporeSigma) at 100 U/ml in 50 mM
ammonium bicarbonate (pH 8.4), were added to the func-
tionalized sections of the slides and incubated for 12 h at 37°C.
The slides were then rinsed with 12 3 200 ml of PBS before
analysis by force spectroscopy.
Force spectroscopy measurements
All binding measurements to the potential receptor molecule-
coated glass surfaces were performed in PBS. For inhibition
studies, relevant cognate sugars (lactose, yeast a-mannan, or
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scleroglucan) in PBS were added into the liquid cell at various
concentrations. The experimental data were captured in a so-
called force–volumemode (at a rate of 2mm/s in theZ direction,
at a scan rate of 1 Hz, and at a pixel density of 32 3 32). In this
mode, the instrument ramps the Z piezo element of the scanner
by a predetermined amount at each sample point over a selected
scan area (3 mm) and records the subsequent deflection of the
cantilever as it is pushed toward (maximum load force 300 pN),
then retracted from the sample surface. This produces amatrix of
1024 force vs. distance curves for each tip–sample combination.
The spring constant k of the cantileverswas determinedby fitting
the thermal noise spectra (40), yielding typical values in the range
of 0.01–0.04 N/m.
Analysis of force–distance curves
The adhesion force maps (labeled in a cold–warm color
gradient) were calculated by measuring the difference be-
tween the minimum values seen in the retraction force
curves and the final 10 points where the AFM tip is suffi-
ciently distant from the sample surface so that the cantilever
has no deflection and the force is 0. Therefore, this region of
the force curve is linear and defined as the baseline (MFP-3D
software v.111111+1610; Asylum Research).
Force vs.distance datawere also analyzed by using a custom-
made Excel (Microsoft, Redmond, WA, USA) macro (41). This
approach ensured that any nonspecific tip–sample interac-
tions, which appear at the tip–glass detachment point, were
eliminated from the measurements. The distance between
adhesive events and the tip–sample detachment point (0 nm
in the x axis) in the force spectra were also determined by
using the macro. Peak identification in the retraction data
was performed by identifying turning points, and discrim-
ination from noise was achieved with a user-adjustable
value, which set the threshold level at a 63 multiple of the
noise level amplitude.
Reporter cell assays
BWZ.36 cells expressing murine CLRs mDectin-1, mDectin-2,
and SIGN-R1 were established (42, 43). In brief, the extracel-
lular domain ofmDectin-1 (Ser74 throughLeu244),mDectin-2
(Gln49 through Leu209), or SIGN-R1 (Ser76 through Gly324)
was cloned into the retrovirus vector pMXs-IRES-EGFP-
Ly49A-CD3 harboring the transmembrane region of the
mouse Ly49A and the cytoplasmic domain of themouseCD3z
(42). The resulting pMXs vectors encoding mDectin-1,
mDectin-2, and SIGN-R1 were used for the retrovirus trans-
duction using Plat-E cells (42). To introduce 2 amino acid
mutations into the carbohydrate-binding domain of mDectin-
2 (E168Q and N170D) and SIGN-R1 (E285Q and D287N),
DNA fragment encoding extracellular domain of mDectin-2
and SIGN-R1 with the 2 missense mutations was synthesized
(GenScript) and used for cloning as above.
To assess the binding of different ligands to the C-type lectin
domain, specific ligands were adsorbed on a 96-well microplate
(Thermo Fisher Scientific) overnight at 4°C in PBS. Wells were
washed twice with PBS and BWZ.36 cells (expressing C-type
lectins or mock cells) were added to the wells at 53 105 cells/ml
and incubated for 18 h at 37°C and 5%CO2. After incubation,
cells were centrifuged at 510 g for 3 min and the supernatant
discarded. To measure b-galactosidase activity encoded by
the lacZ reporter gene, 200 ml of 150 mM chlorophenol red-
b-D-galactopyranoside diluted in a CPRG assay reaction
buffer (PBS supplemented with 0.125% Triton X-100, and
100 mM 2-ME) was added to each well. The plate was in-
cubated for 45 min at 37°C, 5% CO2 before measurement of
color development (A570/630 nm) with a Benchmark Plus
Microtiter Plate Reader (Bio-Rad).
Mucin extraction
Mucin extraction was performed as described in Davies et al.
(44). Culture medium from the LS174T cell line was freeze
dried before extraction of MUC2. After freeze drying, sam-
ples were solubilized overnight in a 5 M guanidine chloride
(GuCl) buffer containing protease inhibitors (7.95 mM
EDTA, 12.25 mM benzamidine, 6.25 mMN-ethylmaleimide,
1.25 mM PMSF, 3.75 mM sodium azide, 0.1 mg/ml soy bean
inhibitor). Samples were centrifuged at 12,000 rpm. The
pellet was reduced with 10 mM DTT for 4 h at 45°C and
alkylated with 25 mM iodoacetamide overnight before di-
alysis against 50 mM ammonium bicarbonate. The same
protocol was followed for the mucus scraped from SI and
colon of wild-type (WT) C57BL/6 and C3GnT2/2 mice (21).
Access to mouse tissues was performed under the Animal
Welfare and Ethical Review Body of University of East
Anglia’s establishment license (according to Home Office re-
quirements). Porcine gastric mucin (PGM) type III; Milli-
poreSigma) was further purified with purified porcine gastric
mucin (pPGM) (45). The purity of the mucins was determined
by immunoblot analysis, lectin, and Alcian blue staining after
electrophoresis by SDS-PAGE or vertical agarose gel electro-
phoresis (46).
Characterization of purified mucins
Mucin glycoproteinswere separated by vertical SDS‐agarose gel
electrophoresis (46). In brief, a 1 cm 12% polyacrylamide plug
was cast using 10 3 8 cm glass plates and 1.5 mm spacers (Bio‐
Rad).Afterpolymerization, thepreparationwasoverlaidbya1%
agarose gel (Agarose LE; Melford Biolaboratories, Ipswich,
United Kingdom) prepared in running buffer (50 mM Tris,
384 mM glycine, and 0.1% SDS) containing 30% glycerol. Sam-
ples were electrophoresed at 15 mA for 65 min at 4°C in a Mini‐
ProteanTetraCell device (Bio‐Rad). For electroblotting, gelswere
placed in NuPAGE transfer buffer (Thermo Fisher Scientific)
containing 10%methanol and blotted to 0.45mmHybond PVDF
membrane (Amersham/GE Healthcare Life Sciences, Little
Chalfont, United Kingdom) at 40 V for 2 h 20 min at 4°C in an
Xcell II blot module (Thermo Fisher Scientific). To assess for the
presence of smaller proteins, extractedmucinswere separatedby
SDS-PAGE on a 4–12% Bis-Tris NuPAGE gel (Thermo Fisher
Scientific) in 3-(N-morpholino) propane sulfonic acid–SDS run-
ning buffer according the manufacturer’s protocol. The gel was
stained with Coomassie blue using Instant Blue stain protein
solution (Expedeon; MilliporeSigma). The proteins were trans-
ferred onto a 0.45 mm pore size Hybond PVDF membrane
(Amersham/GE Healthcare Life Sciences).
For immunolabeling or lectin staining, the membrane was
first blockedwith Protein-Free blockingbuffer (ThermoFisher
Scientific) for 60 min and incubated with FITC-WGA lectin at
2.5 mg/ml for 1 h at room temperature or with mouse anti‐
MUC2 (Abcam, Cambridge, United Kingdom) diluted 1:1000
in the blocking buffer overnight at 4°C. The blotswerewashed
with PBS and 0.1% Tween 20. For immunodetection, the blots
were incubated with AlexaFluor 488-conjugated goat anti‐
mouse IgG (Thermo Fisher Scientific) diluted 1:2000 for 1 h in
the blocking buffer, and rinsed with PBS-0.1% and Tween-20.
The blots were imaged with a Pharos FX Plus Imager (Bio-
Rad).
ForAlcian blue staining, themembranewas rinsedwith pure
H2O and transferred into an Alcian Blue solution (25% (v/v)
ethanol, 10% (v/v) acetic acid, and 0.125% (w/v) Alcian Blue
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8GX for 30 min. The blots were destained with 100% methanol
for 15 min, rinsed with pure H2O, air dried, and imaged with a
GS-800 calibrated densitometer (Bio-Rad).
Enzymatic treatment
For N-deglycosylation of mucins by PNGase F, 1 mg of colon
Muc2 from WT and C3GnT2/2 mice was treated with 10 U
PNGase F (Millipore Sigma) for 24 h at 37°C in 50 mM ammo-
nium bicarbonate buffer. The samples were then centrifuged at
15,000 g for 5 min. The pellets were washed 3 times with water,
and the resulting PNGase F-treated mucins used for binding
assays.
Mass spectrometry–glycosylation analysis
Release of oligosaccharides from mucin by alkaline
borohydride treatment
Themucins were subjected to b-elimination under reductive
conditions (0.1 M NaOH and 1 M NaBH4) for 20 h at 45°C.
The reaction was stopped by adding Dowex 5038 (Dow
Chemical Company, Midland, MI, USA) and filtered before
being coevaporated with methanol 3 times. The remaining salts
were removed by Carbograph (Grace Alltech, Columbia, MD,
USA).
Permethylation of O-glycans
Permethylation was performed on released O-glycans from
the different mucin samples. Samples were solubilized in
200 ml DMSO, followed by addition of ;25 mg NaOH and
300ml iodomethane under anhydrous conditions and vigorously
shaken at room temperature for 90 min. The permethylation
reaction was stopped by addition of 1 ml acetic acid (5% v/v).
Permethylated O-glycans were purified on a hydrophilic–
lipophilic balanced copolymer Oasis cartridge (Waters, Hert-
fordshire, United Kingdom). In brief, cartridges were activated
by 100%methanol, equilibratedwithmethanol:water (5:95, v/v),
and the samples loaded onto the cartridges. The cartridgeswere
washedwithmethanol:water (5:95, v/v) and the permethylated
O-glycans were eluted with methanol.
Analysis of permethylated O-glycans by mass spectrometry
Matrix-assisted laser desorption and ionization–time of
flight mass spectrometry (MALDI-TOF MS) and TOF/TOF-
MS data were acquired with the Autoflex analyzer mass
spectrometer (Bruker, Coventry, United Kingdom) in the
positive-ion and reflectronmode. Samples were dissolved in
methanol/water (1:1 v/v) and mixed with an equal volume
of 2,5-dihydroxibenzoic acid (10 mg/ml in 70:30 methanol:
water; MilliporeSigma) and spotted onto an MTP 384 target
plate polished steel TF (Brucker). Six spectra of 500 shots
were accumulated from a range of m/z 500 to 4000. Peaks
observed in the MS spectra were selected for further tandem
MS (MS/MS) analysis without the collision-induced disso-
ciationmode.MS/MSdata comprises a total of 50 subspectra
of 2000 shots.
C-type lectin glycosylation analysis
Each C-type lectin (50 mg mDectin-1, mDectin-2, and SIGN-
R1) was incubated in 50 mM ammonium bicarbonate buffer
with 10U PNGase F (recombinant PNGase F of Flavobacterium
meningosepticum; MilliporeSigma) for 24 h at 37°C. The re-
action was stopped by freeze drying. The released N-glycans
were then purified on C18-SepPak cartridges (Waters). Car-
tridges were activated by 5 ml methanol, equilibrated with
5ml acetic acid (5%, v/v), 5 ml acetonitrile, and 10ml of acetic
acid (5%, v/v). Samples were solubilized into 200 ml acetic
acid (5%, v/v) and loaded onto the cartridges. The flow-
through was collected, and cartridges were washed with
10 ml acetic acid (5%, v/v) and the solutions freeze dried
before the permethylation of purified N-glycans.
N-glycosylation analysis of mucins
ColonMuc2 (1.5mg) fromWTandC3GnT2/2micewas digested
by 500 mg of trypsin in 50 mM ammonium bicarbonate buffer at
37°C for 24 h. Trypsinwas inactivated by heating the samples for
5 min at 100°C. The samples were freeze dried, and the purifi-
cation of mucin peptides was performed with a hydrophilic–
lipophilic balancedOasis cartridge (Waters). The cartridgeswere
activated and equilibrated with 5 ml methanol, 5 ml acetic acid
(5% v/v), 5 ml propan-1-ol, and 15 ml acetic acid (5% v/v). The
digested samples were loaded onto the cartridges, washed with
20 ml acetic acid (5% v/v), and eluted with 20% (v/v) and
40% (v/v) of propan-1-ol. The eluate was evaporated under
nitrogen before freeze drying.
The eluted peptides were dissolved in 50 mM ammonium
bicarbonate and treated with 10 U PNGase F at 37°C for 24 h.
Released glycans were purified on a Sep-Pak C18 Classic car-
tridge (Waters), prewetwith5mlmethanolandequilibratedwith
5 ml acetic acid (5% v/v), 5 ml acetonitrile, and 10 ml acetic acid
(5% v/v). After the samples were loaded onto the cartridge, the
releasedglycanswere elutedwith 10ml acetic acid (5%v/v). The
eluant was freeze dried and prepared for MALDI-TOF-MS
analysis.
Permethylation of N-glycans
Permethylation was performed on released N-glycans from
the different C-lectins andmucins. Samples were solubilized
in 200 ml DMSO, and 25 mg NaOH (1.25 M in final concen-
tration) and 300 ml iodomethane were added in anhydrous
conditions followed by vigorous shaking at room tempera-
ture for 90 min. The permethylation reaction was stopped
by addition of 1 ml acetic acid (5% v/v). Permethylated
N-glycans were extracted by chloroform. The chloroform
phases were washed 3 times with acetic acid (5% v/v) and
3 times with water before evaporation under nitrogen. The
permethylatedN-glycans were then purified on C18-SepPak
cartridges. Cartridges were conditioned sequentially with
5mlmethanol, 5 mlwater, 5 ml acetonitrile, and 10ml water.
Permethylated N-glycans were resuspended into 200 ml
methanol:water (50:50 v/v), loaded onto a C18-SepPak
cartridge, washed with 15 ml water and 2 ml acetonitrile
(10% v/v), and eluted sequentially with 1ml (35% v/v), 1 ml
(50% v/v), and 2 ml (80% v/v) acetonitrile. The eluate was
evaporated under nitrogen before freeze drying and was ana-
lyzed by MS with the Bruker Autoflex Analyzer Mass Spec-
trometer (Thermo Fisher Scientific) in the positive-ion and
reflectron mode by using 2,5-dihydroxibenzoic acid (10 mg/ml
in 70:30 methanol:water; MilliporeSigma) as the matrix.
Mucin chemical deglycosylation
Desialylation of mucins
Mucins were desialylated by 0.1 M trifluoroacetic acid (TFA;
MilliporeSigma) treatment at 80°C for 1 h and then dialyzed
against water.
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Sequential de-O-glycosylation of mucins
After desialylation, de-O-glycosylation based on the oxidation
and elimination method was performed according to published
methods (47). In brief, 2.5 mg of mucins were coated onto a
96-well microplate (Fluotrac/Greiner Bio-One; MilliporeSigma).
Mucins were incubated with 200 ml 10 mM sodium metaper-
iodate in 0.1 M sodium acetate buffer at 37°C for 1 h. The wells
were washed 3 times with H2O and incubated with 25% am-
monium hydroxide at room temperature for 1 h. Three cycles
were performed to sequentially remove monosaccharides from
mucin glycans. Finally, the samples were treated with 25%
NH4OHat 37°C for 2h after the last periodate oxidation (37°C for
1 h) to remove any core-GalNAc.
To test the efficiency of deglycosylation assays, native and
chemically treated mucins were tested against a range of FITC-
conjugated lectins, including WGA, RCA, and UEA. After
treatment,mucinswerewashedwithPBS andblocked overnight
with Pierce Protein-Free Blocking Buffer (Thermo Fisher Scien-
tific). Thewells werewashedwith PBS and 0.05% and Tween-20
and incubated with FITC-labeled lectins (dilution 1:1000 in
blocking buffer) for 1 h in the dark. After a final wash with PBS,
the fluorescence was detected by excitation at 488 nm and
emission at 525 nm using a FluoStar Optima Microplate Reader
(BMGLabtech, Aylesbury, United Kingdom). Confirmationwas
also obtained by MS analysis with deglycosylated purified
pPGM.
Statistical analysis
A 1-way ANOVA, followed by Tukey’s test, or 2-way ANOVA
were used for statistical analysiswith Prism software (GraphPad
Software, La Jolla, CA,USA). A value ofP, 0.05was considered
significant.
RESULTS AND DISCUSSION
Gal-3 binds to mucins via poly
(LacNAc) glycans
Galectins represent a family of carbohydrate-binding
proteins with affinity for b-galactoside sugars. Gal-3, the
only chimera galectin found in vertebrates, consists of
1 CRD connected to a collagen-like sequence formed by
Pro-Gly-Tyr tandem repeats and an N-terminal domain
(35). Gal-3 can accommodate various b-galactosides in its
canonical-binding site, with high affinity toward histo-blood
group epitopes, ganglioside GM1-pentasaccharide and clus-
teredcore-1O-glycans.Gal-3 recognizesN-acetyllactosamine
(LacNAc; Galb1-4GlcNAc), and, in particular, internal
LacNAcwithin poly-N-acetyllactosamine (poly-LacNAc)
(48, 49). Gal-3 has been shown to interact with glycosy-
latedMUC2 via the formation of a complex with Dectin-1
and FcgRIIB on DCs enhancing gut homeostasis and oral
tolerance (32).However, thenatureofO-glycansmediating
the interaction of Gal-3 with mucins forming the intestinal
mucus layer in the GI tract has not been investigated.
We showed that Gal-3 binds to a range of mucins pu-
rified from different sources including gel-formingMUC2
from human cell lines LS174T, Muc2 from SI and colon
frommurine models, conventionally raisedWT C57BL/6
mice or C3GnT2/2 mice (21), and MUC6 purified from
commercial pPGM (Supplemental Figs. S1 and S2). Bind-
ing was stronger to pPGM as compared to mouse Muc2
and MUC2 from LS174T cells (Fig. 1). Significant binding
to Gal-3 was observed for all mucins tested at 20 mg/ml,
and bindingwas completely inhibited by 100mM lactose,
suggesting that binding occurs through Gal-3 CRD. Gal-3
bound to pPGM in a concentration-dependent manner.
No significant differences were found within the murine
mucins (WT and C3GnT2/2) purified either from the SI or
colon. Higher variability in Gal-3 binding to Muc2 from
WT and C3GnT2/2 mouse colon may be related to lower
solubility of colonic Muc2 at higher concentration.
The interaction betweenGal-3 and the differentmucins
was further investigated by direct single molecular mea-
surement with force spectroscopy (Fig. 2). Mucins were
covalently attached to the glass surface via theirN-termini,
enabling the mucin glycan chains to protrude into the
aqueous liquid buffer, and Gal-3 was covalently attached
to theAFMtip. Figure 2 includes adhesion forcemaps (top
panels) revealing the level of adhesive events in the
force–distance–scanned regions, example force–distance
curves (middle panels), and histograms (bottom panels)
that show the quantification of the adhesive events de-
tected across the entire 1024 force spectra within the force
volume–mapped regions. In the example, force–distance
curves, the red line represents the ligand functionalized tip
approaching the sample surface from severalmicrometers
Figure 1. Binding of Gal-3 to mucins is dose
dependent and inhibited by lactose. Recombi-
nant Gal-3 was incubated at different concen-
trations (0, 1.25, 2.5, 5, 10, and 20 mg/ml) for 2
h at 37°C on a 96-well plate coated with 100 ml
of mucins (10 mg/ml). The binding was
assessed against MUC6 (pPGM), Muc2 from
WT or C3GnT2/2 mice puriﬁed from SI or
colon (C), MUC2 puriﬁed from LS174T cells,
and bovine serum albumin (negative control).
The binding of Gal-3 was inhibited against all
the mucins coated at 20 mg/ml in the presence
of 100 mM lactose solution. Data are represen-
tative of 3 independent experiments with
similar results. Error bars, denote the SD.
Statistical signiﬁcance of differences were de-
termined by 2-way ANOVA. *P , 0.05,
**P , 0.01, ****P , 0.0001.
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Figure 2. Force spectroscopy of Gal-3 interactions with mucins. Adhesion maps, examples of force curves, and adhesion
histograms of Gal-3 with MUC6 pPGM in PBS (A) or in the presence of 200 mM lactose (D); colonic Muc2 from C3GnT2/2 mice
in PBS (B) or in the presence of 200 mM lactose (E); MUC2 from LS174T cells in PBS (C) or in the presence of 200 mM lactose
(F). G) Gal-3–pPGM adhesion separation distances. Inset: example of a force–distance curve. Gal-3 was attached to the AFM tip
via a PEG linker, and mucins were covalently attached to the glass slide via their N termini, resulting in the mucin glycan chains
protruding into the aqueous liquid buffer.
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and theblue line the retraction forcedata collectedafter the
tip engaged with the sample. When adhesion occurs,
negative peaks appear in the retraction curves (but not in
the approach curves). The negative peaks are nonlinear,
because both thePEG linker, on the functionalized tip, and
the mucin chains attached to the glass slide are stretched
until the ligand–receptors are pulled apart. The example
force–distance curves between Gal-3 and the different
Figure 3. Structural charac-
terization of mucin O-glycans
by MS. MALDI-MS spectra,
acquired in the positive-ion
mode [M + Na]+ of perme-
thylated O-glycans from pPGM
(A), MUC2 from LS174T
cells (B), Muc2 from SI (C)
and colon (D) of C3GnT2/2
mice, and Muc2 from SI
(E) and colon (F) of WT
mice. Monosaccharide sym-
bols follow the Symbol No-
menclature for Glycans
system (81). Key: fucose (red
triangle), GlcNAc (blue
square), sialic acid (purple
diamond), galactose (yellow
circle), and HexNAc (off-
white square).
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mucins tested showed specific interactions occurring at
distances significantly away from the tip–sample de-
tachment point, reflecting the distribution of glycan chains
along themucinmolecules (Fig. 2A–C). Gal-3 bindingwas
stronger to MUC6 pPGM (Fig. 2A) than to mouse colonic
Muc2 (Fig. 2B) or MUC2 from LS174T cells (Fig. 2C), in
agreement with the ELISA results. The addition of free
lactose led toa reduction in the frequencyof the interactions
Figure 3. (Continued)
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(Fig. 2D–F), confirming that Gal-3 bound to mucins via its
CRD,aspreviouslyreportedforpPGM(50).Furthermore, the
Gal-3 adhesion separation distances spread between 117 and
2355 nmwith the inset example force curve showing higher
multipleadhesioneventsover the rangeof thecontour length
ofmucin chains (Fig. 2G), as compared toGunning, et al. (50).
To gain further insight into Gal-3 binding specificity
to mucin glycans, the glycosylation profile of purified
Figure 4. Summary of the mucin O-glycan structures as determined by MS. These include LS174T MUC2, colon WT Muc2, colon
C3GnT2/2Muc2, SI WT Muc2, SI C3GnT2/2Muc2. The relative percentage of each structure is calculated as: [area of the peak/
(sum of peaks areas corresponding to O-glycans)] 3 100.
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mucins was determined by MS. The O-linked oligosac-
charides were released from reducedmucins by reductive
b-elimination, permethylated, and analyzed by MALDI-
TOFandTOF/TOF-MS(Figs.3and4).pPGMshowedcore-
1, derived-core-1, core-3, and derived-core-3 O-glycans, in
agreementwith another study (51). A total of 41 different
O-glycans composed of up to 11 monosaccharides were
identified, with only 4% of the structures being sialy-
lated. The glycosylationprofile of pPGMwasdominated by
shortO-glycans up to 6monosaccharides fromm/z= 534 to
Figure 4. (Continued)
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m/z = 1473. These glycans represent;60% of the total of
pPGM O-glycans (Fig. 3A). LS174T MUC2 was charac-
terized by the presence of 2 major O-glycans, the sialyl-
TF at m/z = 895 and the di-sialyl-TF at m/z = 1256
(constituting about 70% of the totalO-glycans identified
in LS174T MUC2). The proportion of sialylation was
about 92%, in line with previous reports showing that
mucins from LS174T were highly sialylated (52, 53). No
large structures with poly-LacNAc were observed
(Fig. 3B). In C3GnT2/2 SI Muc2, 58% of O-glycans were
sialylated, andonly5%were fucosylated (Fig. 3C),whereas
in colonicMuc2, 34%ofO-glycanswere sialylated and64%
were fucosylated (Fig. 3D). In these mucins, O-glycans
were core-1 and derived-core-1, in agreement with previ-
ous reports (19, 54). C3GnT2/2 mice showed a compete
ablationof all core-3–derivedO-glycans on colonicmucins,
but a retention of core-1– and -2–derived O-glycans as
analyzed by MALDI-TOF MS (21) and confirmed in a re-
cent study (54). Further characterization ofC3GnT2/2mice
revealed that loss of core-3–derived O-glycans led to a
partial exposure of theTnantigen comparedwithWTmice
(21). In WT murine SI Muc2, we observed sialylated
structures with Sda/Cad antigen at m/z = 1140 and 1589,
characterized in MS/MS by the presence of the CY ion
at m/z = 606 (Supplemental Fig. S3) (55) and the presence
of sialyl TF at m/z = 895. The colonic WT mouse Muc2
was characterized by the presence of short fucosylated
O-glycans with blood group H antigen (Fuca1_2Gal-)
characterized in MS/MS by the presence of the C-ion at
m/z=433(SupplementalFig.S3),butnosialylatedO-glycans
were detected in contrast with previous results (54),
whereas C3GnT2/2 colonic Muc2 showed the presence
of sialylated O-glycans at m/z = 1589, 1950, and 2400.
O-glycanswere predominantly core-1 and -2 structures
in agreement with previous results (54).
These structural analyses suggest that the presence of
terminal sialylation and fucosylation in LS174T MUC2
and murine Muc2 hampers recognition of Gal-3 binding
epitopes in mucins. To further determine the specificity of
Gal-3 to intestinal mucin glycans, immobilized mucins
were subjected to cycles of deglycosylation by chemical
treatment based on the oxidation or elimination method
(47). After a mild acid hydrolysis that removed monosac-
charides with weak linkages, such as sialic acid, terminal
monosaccharideswere removed sequentiallybyoxidation
and elimination, asmonitored by ELISAwith plant lectins
(WGA,UEA, andRCA;data not shown). This processwas
further confirmed by MS of pPGM (Supplemental Fig. S4
andTable S1). Poly-LacNAc structureswere detected after
desialylation and after the first cycle of deglycosylation,
which removes all fucose residues and terminal mono-
saccharides. We observed, in particular, an increase in
structures atm/z = 1228, 1473, 1677, 1718, 1922, and 2168.
These structures were characterized by a sequence of
Gal and GlcNAc which forms at least 2 LacNAc motifs.
Binding of Gal-3 to all mucins, except MUC2 from
LS174T cells, was significantly augmented after the first
cycle ofdeglycosylation that removedall the fucose residues
or terminal sugars (Fig. 5).Theproportionof thesestructures
decreased after the second cycle of deglycosylation in favor
of smaller structures at m/z = 534, 575, 779, and 1024,
whichmay explain the decrease in interactionwith Gal-3.
The binding of Gal-3 to MUC2 from LS174T cells did
not increase after deglycosylation, which may be related
to the presence of short glycan structures. Our data
show that Gal-3 preferentially binds to poly-LacNAc struc-
tures that become available after the removal of terminal
monosaccharides in mucin glycan chains. These data are
consistent with results in previous studies showing that
Gal-3 binds only glycans containing at least 3 repeating type
2 LacNAc/lactose structures that lacked branched features
(56, 57).
Mucin binds to mDectin-2 and SIGN-R1,
but not mDectin-1, via lectin–
carbohydrate interactions
Glycans are recognizedbyC-type lectins expressedmostly
bymyeloid antigen-presenting cells, such asmacrophages
and DCs. CLRs belong to the family of antigen uptake
receptors, as they recognize cell surface glycans on many
viruses, bacteria, andparasites, butmaybind and respond
to host endogenous glycoproteins aswell. CLRs recognize
a diverse range of neutral sugars, including mannose,
fucose, glucose, orb-glucan (27, 58). These CLRs possess a
CRD and are capable of mediating intracellular signaling
either directly, through intracellular signaling domains, or
indirectly, by associating with signaling adaptor mole-
cules.Dectin-1 recognizesb-glucansvia interactionwith its
CRD and transduces signals through its immunoreceptor
tyrosine-based activationmotif in the cytoplasmic domain
(29), whereas Dectin-2 recognizes a-mannans and trans-
duces its signal through association with the immunor-
eceptor tyrosine-based activation motif–containing FcR g
chain (59). SIGN-R1 is the murine homolog of DC-SIGN
(60). Ligands for DC-SIGN include fucosylated structures,
including blood group antigens, human milk glycans
(61, 62) or MUC1 via Lewis X structures (34), as well as
high-mannose moieties (63, 64). SIGN-R1was found to be
Figure 5. Binding of Gal-3 to mucins is increased after
desialylation (ds) and several cycles of deglycosylation. MUC6
(pPGM), Muc2 from WT or C3GnT2/2 mice puriﬁed from SI
or colon (C), and MUC2 puriﬁed from LS174T cells were
coated at 10 mg/ml (100 ml/well). Desialylation by mild
hydrolysis followed by 6 cycles of deglycosylation were
performed directly in the microplate. The binding of Gal-3
to native and modiﬁed mucins was assessed after incubation
for 2 h at 37°C, followed by colorimetric reaction. Data are
representative of 3 independent experiments with similar
results. Error bars denote the SD.
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Figure 6. Interaction of mucins with CLRs. Cell reporter assays were performed to screen the interaction of SI or colon Muc2 from
WT and C3GnT2/2 mice, pPGM (MUC6) and LS174T MUC2 with mDectin-2 and QPD-mutant reporter cells (A), mDectin-1
reporter cells (C), and SIGN-R1 and QPD-mutant reporter cells (D). B, E) Binding between native and PNGase F–treated WT colon
Muc2 with mDectin-2 reporter cells and SIGN-R1 reporter cells, respectively. Saccharomyces cerevisiae a-mannan was used as a positive
control for mDectin-2 and SIGN-R1, and scleroglucan for mDectin-1, respectively. Mucins were used at 100 mg/ml, scleroglucan at
1 mg/ml, a-mannan at 2 mg/ml, and 100 ml of each was used for immobilization in the wells. Data are representative of
3 independent experiments with similar results. Error bars denote the SD. *P , 0.05, **P , 0.01, ***P , 0.001 (by ANOVA).
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a major mannose receptor for fungal and other pathogens
(65). Dectin-2 clearly recognizes mannose-type ligands,
although the precise nature of these ligands differs from
those recognized by SIGN-R1 (66).
Using reporter cells expressing individual CLRs on the
cell surface (42, 43), we assessed the binding of a range of
mucins tomDectin1,mDectin-2, and SIGN-R1 (Fig. 6).We
showed a significant binding of WT SI and colonic Muc2
to mDectin-2, whereas less binding was detected for
C3GnT2/2 Muc2 (SI and colon), pPGM, and LS174T
MUC2 (Fig. 6A). Therewas no binding ofmucins tomock
cells (used a negative control) and the binding of WT SI
andcolonicMuc2was reducedwhenmucinwas incubated
with reporter cells expressing the mDectin-2QPDmutant in
which the mannose-binding activity was eliminated by
substituting glutamic acid-proline-asparagine sequence
into the galactose-type QPD, indicating the specificity of
the interaction. Dectin-2 CRD recognizes high-mannose
ligands found in diverse microbes (67). AFM confirmed
direct interaction between mDectin-2 and WT colonic
Muc2, showing a total number of adhesion events of
1018 (Fig. 7A). In addition, the large range of adhesion
distance events revealed that the interactions occur along
the entire length of the Muc2 chain as illustrated by the
example force curve. To determine whether binding of
mDectin-2 to mucins is mediated by N-linked high
mannose of mucins, we carried outN-glycan profiling of
colonic Muc2 from WT by MS. Reduced and alkylated
mucins were first digested by trypsin before PNGase
F treatment to allow release of N-glycans. We showed
Figure 7. Force spectra histograms of adhesion between murine C-type lectins and mucin. A) Left: mucin adhesion quantiﬁcation
of mDectin-2 against WT colonic Muc2 or PNGase F–treated Muc2; right: mDectin-2- WT colonic Muc2 tip–sample adhesion
separation distances. B) Left: mDectin1–pPGM adhesion quantiﬁcation; right: mDectin1–pPGM tip–sample adhesion separation
distances. Insets in right panels: examples of force–distance curves. C) SIGN-R1-WT colonic Muc2. Colonic Muc2 was covalently
attached to the glass slide, C-type lectins were attached to the AFM tip via the PEG linker. Competition with S. cerevisiae a-mannan
is included in the adhesion histograms.
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that WT colonic Muc2 from mice harbored high-
mannose N-glycans from Man5GlcNAc2 at m/z = 1579
to Man9GlcNAc2 at m/z = 2396 (Fig. 8A and Supple-
mental Table S2). Note that a singleN-glycan of the high-
mannose type was reported in the recombinant human
MUC2 C-terminus produced in CHO-K1 cells (68). A
marked decrease in binding was detected with PNGase
F–treated colonic Muc2, as shown in an mDectin-2
reporter cell assay (Fig. 6B) and force spectroscopy (Fig.
7A). The total number of adhesion events dropped from
1018 with Muc2 to 72 when mDectin-2 was assayed
against PNGase F–treated Muc2. Both the modal values
of adhesion event frequencies and of adhesionmagnitude
decreased against PNGase F–treated Muc2 (20 events of
43 pN), as compared to nontreated Muc2 (133 events of
94 pN). PNGase F treatment alone did not fully abolish
the binding that may be related to a partial removal of
N-glycans, the possible contribution of additional factors
including other glycan epitopes, or both. However, the
addition of yeast a-mannan to the liquid cell caused a
further reduction of the modal adhesion event frequen-
cies (11) and the total number of adhesion events drop-
ped to 32, further supporting that the interaction occurs
between mDectin-2 CRD and N-glycosylation epitopes
in Muc-2. Oligomannosylated N-glycans were also pre-
sent inC3GnT2/2Muc2 (Fig. 8B and Supplemental Table
S2). However, we cannot exclude that fewer glycan
structures may be responsible for the observed differ-
ences in binding betweenWTandC3GnT2/2 colonMuc2.
On the other hand, although the family of oligomanno-
sylatedN-glycans fromMan5GlcNAc2 toMan9GlcNAc2
were clearly detected in spectra of colonMuc2N-glycans,
only oligomannosylated N-glycans at m/z = 1783 and
1987 were found in pPGM with fucosylated N-glycans
representing the major structures (data not shown),
which could explain the low interaction observed between
pPGM and mDectin-2.
In contrast to the significant binding of WT SI and
colonicMuc2 tomDectin-2, we did not detect any binding
of mucin to mDectin-1 via the cell reporter assay (Fig. 6C).
Figure 8. Structural character-
ization of mouse colonic Muc2
N-glycans. MALDI-MS spectra,
acquired in the positive ion
mode [M+Na]+ of permethy-
lated N-glycans from colonic
Muc2 from WT (A) and
C3GnT2/2 (B) mice after treat-
ment by trypsin and PNGase F.
Monosaccharide symbols follow
the Symbol Nomenclature for
Glycans system (81). Key: fu-
cose (red triangle), GlcNAc
(blue square), sialic acid (pur-
ple diamond), N-glycolyl sialic
acid (light blue diamond), ga-
lactose (yellow circle), and
mannose (green circle).
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This lack of binding between mDectin-1 and mucin was
further confirmedby force spectroscopy (Fig. 7B). ThePEG
linker used in the tip functionalization allows discrimina-
tion of specific and nonspecific adhesion events in force
curves (69). Occasional nonspecific adhesions because of
attractions between the tip and the sample surface occurs
at the tip–sample detachment point, which is 0 nm on the
x-axis and the gradient is linear, matching the bending of
the AFM cantilever. We confirmed that the small number
of adhesion events in the force spectra data of mDectin-1
Figure 9. Structural character-
ization of mice C-type lectin
N-glycans. MALDI-MS spectra,
acquired in the positive ion
mode [M+Na]+ of permethy-
lated N-glycans from recombi-
nant C-type lectins from
mDectin-1 (A), mDectin-2 (B),
and SIGN-R1 (C). Monosaccha-
ride symbols follow the Symbol
Nomenclature for Glycans sys-
tem (81). Key: fucose (red tri-
angle), GlcNAc (blue square),
sialic acid (purple diamond),
N-glycolyl sialic acid (light blue
diamond), galactose (yellow cir-
cle), and mannose (green
circle).
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against mucin (Fig. 7B) were nonspecific, as is clearly
shownby theexample force curve in the inset.This result is
in marked contrast to the force measurements between
mDectin-2 and mucin (Fig. 7A). These data are consistent
with those in studies showing specificity of Dectin-1 for
b-1,3-glucan, a polymer of glucose present in the fungal
cell wall (70–72) and unlikely to recognizemucin glycans.
Colonic Muc2 fromWTmice and intestinal Muc2 from
C3GnT2/2 mice interacted with SIGN-R1 in reporter cell
assays (Fig. 6D). No binding was detected to mock cells
(negative control) or SIGN-R1-QPD, supporting the
specificity of the binding to the CRD of SIGN-R1. Al-
though SIGN-R1 has also been shown to bind tomannose
structures in fungal and other pathogens (65), treating
colonicMuc2withPNGase Fdidnot reduce the binding to
SIGN-R1 reporter cells (Fig. 6E). SIGN-R1 can also bind to
fucose (73), and it is possible that binding to Muc2 is via
fucosylated O-glycans (Fig. 3D). The high-resolution
crystal structures of SIGN-R1 CRD in complex with sia-
lylated ligands revealed the presence of an additional
binding site,whichmay allowSIGN-R1 to simultaneously
bind both immune glycoproteins and microbial polysac-
charide components (74). Figure 7C shows the histogram
of the interactions between SIGN-R1 and colonicMuc2, as
measured by force spectroscopy. The modal value of ad-
hesions occurred mostly at 292 pN but some binding
events also occurred at 3212 pN. Addition of yeast
a-mannan caused some reduction in interactionsadhesion
events, but the modal value of adhesion remained high,
at 1008 pN. However, there was only a low number of
specific interaction events (8 in PBS and 2 after a-mannan
addition). The frequency, presented as the percentage of
the 1024 force curves performed in each experiment,
illustrates the rarity of interactions. It is worth noting that
bindingwas also observed between colonicWTMuc2 and
human recombinant lectins, hDectin-2 and DC-SIGN,
with similar adhesion magnitude range between these
lectins, whereas interaction with hDectin-1 was reduced,
in broad agreement with the results obtained with mouse
lectins (Supplemental Fig. S5).
CLRs, mDectin-1, mDectin-2, and SIGN-R1, are
N-glycosylated and bind to Gal-3
Dectin-1 is glycosylated, a modification that contributes
to its surface expressionand function (75).Oneof themajor
differencesamongmurineandhuman isoformsofDectin-1
is theposition andnumber ofN-linkedglycosylationmotifs.
mDectin-1 was previously reported to be N-glycosylated
with terminal galactose sometimes capped with
N-acetylneuraminic acid (76), but no structural in-
formation is available on the glycosylation ofmDectin-2 or
SIGN-R1.ThededucedaminoacidsequencesofmDectin-2
from murine DC line XS52 indicate the presence of a pu-
tativeN-glycosylationsite in theCRDdomain (77)whereas
SIGN-R1 presents 2 N-glycosylation sites, according to
Uniprot (http://www.uniprot.org/uniprot/Q8CJ91).
To gain further structural insights into the nature of
glycans decorating C-type-lectins, we performedMS anal-
ysis of recombinant mDectin-1, mDectin-2, and SIGN-R1.
All 3 C-type lectins were found to be N-glycosylated.
mDectin-1 andmDectin-2, both produced in theNSO cell
line derived fromnonsecretingmurinemyeloma, showed
similarN-glycan structures (Supplemental Table S3). Two
major N-glycans at m/z = 2652 and m/z = 3305 were ob-
served in mDectin-1 and mDectin-2, corresponding to
fucosylated structures with 2 and 3 antennae terminated
by 2 Gal residues (Fig. 9A, B and Supplemental Fig. S6).
SIGN-R1 presented oligomannosylated and complex-type
Figure 10. Force spectra histograms of adhesion between Gal-3
and murine C-type lectins. A) Interaction between Gal-3 and
untreated or PNGase F–treated mDectin-1. Gal-3 was attached
to the AFM tip and mDectin-1 to a slide. Inset: example
force–distance curve. B) Interaction between Gal-3 and
untreated or PNGase F–treated mDectin-2. (C) Interaction
between Gal-3 and untreated or PNGase F–treated SIGN-R1.
Gal-3 was attached to a slide and mDectin-2 or SIGN-R1 on the
AFM tips.
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bi-,tri-antennaryN-glycans,withmajorglycansatm/z=1579
(oligomannosylated glycans), m/z = 2244, m/z = 2285,
m/z = 2489, m/z = 2605, and m/z = 3054 which are
fucosylated, capped with Neu5Ac, or both. (Fig. 9C).
These N-glycans found in mDectin-1, mDectin-2, and
SIGN-R1 could represent potential ligands for Gal-3, in
particular the potential b-1,6-N-acetylglucosamine an-
tennapresent inall 3C-type lectins.To test this hypothesis,
these CLRs were tested for their binding to Gal-3 by force
spectroscopy. Previous work showed that Gal-3 was in-
volved in an interaction with Dectin-1-FcgRIIB-MUC2
complex on DCs (32). However, the detailed binding
properties have not been clarified and structurally char-
acterized. We showed that Gal-3 recognizes mDectin-1,
mDectin-2, and SIGN-R1 via a carbohydrate–lectin inter-
action. Force spectroscopymeasurements showed specific
interactionsbetweenGal-3 and these ligands (Fig. 10). The
inset example force–distance curves in Fig. 10A illustrates
that the adhesion events between the 2 discrete globular
proteins, Gal-3, and mDectin-1, is singular (i.e., not mul-
tiple), in contrast to themultiple and long-range adhesion
events seen when Gal-3 interacts with mucin. The modal
value of the adhesive interactions between Gal-3 and
mDectin-1 was 49.68 pN. Figure 10B, C shows the in-
teraction betweenGal-3 attached to a slide andmDectin-2
or SIGN-R1onAFMtips, respectively. Themodalvalue of
adhesion between Gal-3 and mDectin-2 was 46.55 pN,
whereas the modal value of adhesion between Gal-3 and
SIGN-R1was 17.08 pN, PNGase F-treatment significantly
reduced the frequency of interactions, further supporting
that binding of Gal-3 to these C-type lectins is via N-linked
b-galactose structuresdecorating recombinantmDectin-1,
mDectin-2, andSIGN-R1. These results are also in linewith
the reported high affinity of Gal-3 for b-1,6-N-GlcNAc
branched glycans (42).The importance of glycosylation
on the biologic function of someCLRs has been reported,
including E-selectin (78), LOX-1 (79), class I major his-
tocompatibility complex–binding receptors (80), and
more recently Dectin-1 (75). The comprehensive struc-
tural characterization of the N-glycans decorating
mDectin-1, mDectin-2, and SIGN-R1, as reported here,
provides a basis for mechanistic follow-up studies. The
glycosylation of C-type lectins inmyeloid andnonmyeloid
cells may play a key and unrecognized role in mediating
crucial cellular functions during immunity and homeo-
stasis, and a potential mechanism for the clustering of
C-type lectins andGal-3 via the recognition of glycans on
self-proteins.
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